YiChang HEC ChangJiang Pharmaceutical Statistics
Share Statistics
YiChang HEC ChangJiang Pharmaceutical has 2.69B
shares outstanding. The number of shares has increased by 6.86%
in one year.
| Shares Outstanding | 2.69B |
| Shares Change (YoY) | 6.86% |
| Shares Change (QoQ) | 0.76% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 8.92M, so 0% of the outstanding
shares have been sold short.
| Short Interest | 8.92M |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 999.99 |
Valuation Ratios
The PE ratio is 7.32 and the forward
PE ratio is 0.29.
YiChang HEC ChangJiang Pharmaceutical's PEG ratio is
-0.1.
| PE Ratio | 7.32 |
| Forward PE | 0.29 |
| PS Ratio | 0.95 |
| Forward PS | 0.3 |
| PB Ratio | 0.42 |
| P/FCF Ratio | -3.23 |
| PEG Ratio | -0.1 |
Financial Ratio HistoryEnterprise Valuation
YiChang HEC ChangJiang Pharmaceutical has an Enterprise Value (EV) of 4.36B.
| EV / Sales | 1.17 |
| EV / EBITDA | 4.08 |
| EV / EBIT | 48.8 |
| EV / FCF | -3.99 |
Financial Position
The company has a current ratio of 1.77,
with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.77 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | -2.05 |
| Interest Coverage | 6.92 |
Financial Efficiency
Return on Equity is 5.67% and Return on Invested Capital is 5.16%.
| Return on Equity | 5.67% |
| Return on Assets | 3.88% |
| Return on Invested Capital | 5.16% |
| Revenue Per Employee | $806,362.71 |
| Profits Per Employee | $104,528.37 |
| Employee Count | 4,618 |
| Asset Turnover | 0.3 |
| Inventory Turnover | 1.44 |
Taxes
| Income Tax | 94.52M |
| Effective Tax Rate | 16.37% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 0.11, so YiChang HEC ChangJiang Pharmaceutical's
price volatility has been higher than the market average.
| Beta | 0.11 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 100 |
| Average Volume (20 Days) | 2,755 |
Income Statement
In the last 12 months, YiChang HEC ChangJiang Pharmaceutical had revenue of 3.72B
and earned 482.71M
in profits. Earnings per share was 0.55.
| Revenue | 3.72B |
| Gross Profit | 2.79B |
| Operating Income | 674.47M |
| Net Income | 482.71M |
| EBITDA | 1.07B |
| EBIT | 674.76M |
| Earnings Per Share (EPS) | 0.55 |
Full Income StatementBalance Sheet
The company has 1.4B in cash and 2.23B in
debt, giving a net cash position of -831.06M.
| Cash & Cash Equivalents | 1.4B |
| Total Debt | 2.23B |
| Net Cash | -831.06M |
| Retained Earnings | 4.43B |
| Total Assets | 12.43B |
| Working Capital | 2.19B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 89.42M
and capital expenditures -1.18B, giving a free cash flow of -1.09B.
| Operating Cash Flow | 89.42M |
| Capital Expenditures | -1.18B |
| Free Cash Flow | -1.09B |
| FCF Per Share | -1.24 |
Full Cash Flow StatementMargins
Gross margin is 75.03%, with operating and profit margins of 18.11% and 12.96%.
| Gross Margin | 75.03% |
| Operating Margin | 18.11% |
| Pretax Margin | 15.5% |
| Profit Margin | 12.96% |
| EBITDA Margin | 28.75% |
| EBIT Margin | 18.11% |
| FCF Margin | -29.34% |
